Literature DB >> 24055813

MARVELD1 regulates integrin β1-mediated cell adhesion and actin organization via inhibiting its pre-mRNA processing.

Shan Wang1, Jianran Hu, Yuanfei Yao, Ming Shi, Lei Yue, Fang Han, Hao Zhang, Jie He, Shanshan Liu, Yu Li.   

Abstract

Cell adhesion on an extracellular matrix (ECM) participates in cell motility, invasion, cell signal transduction and gene expression. Many nuclear proteins regulate cell-ECM adhesion through managing the transcription of cell adhesion-related genes. Here, we identified MARVEL [MAL (The myelin and lymphocyte protein) and related proteins for vesicle trafficking and membrane link] domain containing 1 (MARVELD1) that could suppress cell spreading and complicate actin organization. Over-expression of MARVELD1 in NIH3T3 cells decreased the expression level of integrin β1 and vinculin, and further led to dephosphorylation of focal adhesion kinase (FAK) at Tyr 397. We also found that MARVELD1 partially colocalized with serine/arginine-rich splicing factor 2 (SC35) and interacted with nuclear cap binding protein subunit 2 (CBP20). Finally, we demonstrated that pre-mRNA processing of integrin β1 was affected by MARVELD1. Taken together, our studies demonstrate that MARVELD1 plays a role in pre-mRNA processing of integrin β1, and thereby regulates cell adhesion and cell motility. These studies provide a novel regulatory mechanism of cell-ECM adhesion by nuclear protein in cells.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Actin organization; Cell adhesion; Integrin β1; MARVELD1; Pre-mRNA processing

Mesh:

Substances:

Year:  2013        PMID: 24055813     DOI: 10.1016/j.biocel.2013.09.006

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  5 in total

1.  Biological and clinical significance of epigenetic silencing of MARVELD1 gene in lung cancer.

Authors:  Ming Shi; Shan Wang; Yuanfei Yao; Yiqun Li; Hao Zhang; Fang Han; Huan Nie; Jie Su; Zeyu Wang; Lei Yue; Jingyan Cao; Yu Li
Journal:  Sci Rep       Date:  2014-12-18       Impact factor: 4.379

2.  Epigenetic modifications inhibit the expression of MARVELD1 and in turn tumorigenesis by regulating the Wnt/β-catenin pathway in pan-cancer.

Authors:  Jingchun Zhang; Qingwei Li; Qinliang Sun; Bojun Wang; Ying Cui; Changjie Lou; Yuanfei Yao; Yanqiao Zhang
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207

Review 3.  Application potential of toll-like receptors in cancer immunotherapy: Systematic review.

Authors:  Ming Shi; Xi Chen; Kangruo Ye; Yuanfei Yao; Yu Li
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

4.  MARVELD1 depletion leads to dysfunction of motor and cognition via regulating glia-dependent neuronal migration during brain development.

Authors:  Weizhe Liu; Fang Han; Shuai Qu; Yuanfei Yao; Jianxiang Zhao; Muhammad Luqman Akhtar; Yanpeng Ci; Hao Zhang; Hongfei Li; Yufang Zhao; Lei Yue; Yao Zhang; Changlin Wang; Yu Li
Journal:  Cell Death Dis       Date:  2018-09-24       Impact factor: 8.469

Review 5.  The nuclear cap-binding complex as choreographer of gene transcription and pre-mRNA processing.

Authors:  Xavier Rambout; Lynne E Maquat
Journal:  Genes Dev       Date:  2020-09-01       Impact factor: 12.890

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.